Additionally, estrogen receptor signaling likely has an impact on other aspects of HCC biology, but we chose to focus on Wnt/B-catenin given the impact of ER-a agonist treatment on this critical HCC pathway. The gene discussed is ESR1; the disease is hepatocellular carcinoma.